文献速递抗栓抗凝管理药物不良反应与药物警戒

口服抗凝药相关严重血栓栓塞与出血事件的可预防性:前瞻性研究

Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.
PubMed 文献 · Br J Clin Pharmacol · 2018-04-17

该前瞻性观察研究纳入两所教学医院急诊科2015年7月至2016年1月因DOAC或VKA治疗期间发生血栓或出血事件入院的患者,由四名独立评审员评估严重药物不良反应的可预防性。结果显示DOAC相关严重不良反应53%潜在可预防,VKA相关为61%,处方问题和监测不足分别是DOAC和VKA的常见原因。

要点

  • 超过半数口服抗凝药相关严重不良反应潜在可预防
  • DOAC可预防性相关因素包括处方问题和药物相互作用
  • VKA可预防性相关因素包括监测不足和沟通缺乏

核心结论

  • DOAC和VKA相关严重不良反应中分别有53%和61%被判定为潜在可预防。
  • 针对处方、患者教育和连续性照护的干预应有助于改善DOAC的临床使用。

研究设计与样本

  • 前瞻性观察研究,纳入两所教学医院急诊科2015年7月至2016年1月因DOAC或VKA治疗期间发生血栓或出血事件入院的患者。
  • 分析纳入46例DOAC患者和43例VKA患者,中位年龄79岁。
  • 由四名独立评审员使用预试验量表评估因果关系、严重性和可预防性;对严重且潜在可预防的病例与全科医生进行半结构化访谈。

主要发现

  • 胃肠道出血(n=34)和颅内出血(n=16)是最常见的不良反应。
  • DOAC相关严重不良反应中53%被判定为潜在可预防,VKA相关为61%。
  • DOAC可预防性相关因素中处方问题常见,VKA中监测不足常见。
  • 可预防不良反应的原因包括药效学药物相互作用和沟通缺乏,适用于所有口服抗凝药。

临床怎么用

  • 对口服抗凝药治疗患者应关注处方合理性、患者教育和照护连续性以减少可预防的严重不良反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine the preventability of serious adverse drug reactions (ADRs) related to the use of direct oral anticoagulants (DOACs), and to explore contributing factors to preventable ADRs. Results were compared with vitamin K antagonists (VKAs). METHODS: We conducted a prospective observational study in the emergency departments of two teaching hospitals from July 2015 to January 2016. Patients admitted with a thrombotic or bleeding event while under DOAC or VKA were included. Four independent reviewers assessed causality, seriousness and preventability of ADRs using pilot-tested scales. For cases of serious and potentially preventable ADRs, we performed semi-structured interviews with general practitioners to identify contributing factors to ADRs. The primary outcome was the proportion of serious ADRs that were potentially preventable. RESULTS: The analysis included 46 DOAC and 43 VKA patients (median age 79 years). Gastrointestinal (n = 34) and intracranial (n = 16) bleedings were the most frequent ADRs. Results were that 53% of DOAC- and 61% of VKA-related serious ADRs were deemed potentially preventable. Prescribing issues and inadequate monitoring were frequent for DOAC and VKA respectively. We identified many causes of preventable ADRs that applied to all oral anticoagulants, such as pharmacodynamic drug interactions and lack of communication. CONCLUSIONS: More than half of serious ADRs were potentially preventable for both DOACs and VKAs. Interventions focusing on prescribing, patient education and continuity of care should help improve the use of DOACs in practice.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Sennesael AL, Larock AS, Devalet B, et al. Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study. Br J Clin Pharmacol. 2018. PMID: 29522647. doi:10.1111/bcp.13580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。